(EPC) Edgewell Personal Care - NYSE
Sector: Consumer Defensive | Industry: Household & Personal Products | Exchange: NYSE (USA) | Market Cap: 1.057m USD | Total Return: 1.3% in 12m
Avg Turnover: 16.3M
EPS Trend: -74.2%
Qual. Beats: 0
Rev. Trend: -81.6%
Qual. Beats: 0
Warnings
High Debt/EBITDA (8.9) with thin interest coverage (0.4)
Interest Coverage Ratio 0.4 is critical
Extended 1w
Tailwinds
Idiosyncratic Leader
Edgewell Personal Care Company (EPC) is a global manufacturer and marketer of personal care products, operating through three primary segments: Wet Shave, Sun and Skin Care, and Feminine Care. Its portfolio includes established brands such as Schick, Wilkinson Sword, Banana Boat, Hawaiian Tropic, and Playtex. Formerly part of Energizer Holdings, the company rebranded in 2015 and maintains a distribution network consisting of direct sales, wholesalers, and third-party distributors.
The company operates within the consumer staples sector, a category characterized by defensive demand patterns as personal hygiene and grooming products are typically essential purchases regardless of economic cycles. Edgewell utilizes a razor-and-blade business model in its Wet Shave segment, where the sale of durable handles drives high-margin, recurring revenue through compatible replacement cartridges.
Investors looking for deeper insights into the companys valuation metrics should consider exploring the data available on ValueRay.
- Wet Shave market share stability against low-cost direct-to-consumer competitors
- Raw material and logistics cost fluctuations impact consolidated gross margins
- Sun Care segment performance relies on seasonal weather patterns and travel
- Feminine Care demand remains inelastic providing stable cash flow during downturns
- Strategic brand acquisitions and portfolio optimization drive long-term revenue growth
| Net Income: -77.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.53 > 1.0 |
| NWC/Revenue: 23.53% < 20% (prev 21.40%; Δ 2.13% < -1%) |
| CFO/TA 0.03 > 3% & CFO 117.3m > Net Income -77.8m |
| Net Debt (996.1m) to EBITDA (112.2m): 8.88 < 3 |
| Current Ratio: 1.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.5m) vs 12m ago -3.53% < -2% |
| Gross Margin: 41.00% > 18% (prev 42.60%; Δ -1.61% > 0.5%) |
| Asset Turnover: 57.67% > 50% (prev 58.96%; Δ -1.29% > 0%) |
| Interest Coverage Ratio: 0.37 > 6 (EBIT TTM 26.4m / Interest Expense TTM 71.4m) |
| A: 0.14 (Total Current Assets 1.11b - Total Current Liabilities 613.8m) / Total Assets 3.53b |
| B: 0.28 (Retained Earnings 995.8m / Total Assets 3.53b) |
| C: 0.01 (EBIT TTM 26.4m / Avg Total Assets 3.65b) |
| D: 0.69 (Book Value of Equity 1.45b / Total Liabilities 2.09b) |
| Altman-Z'' = 2.62 = A |
| DSRI: 1.20 (Receivables 267.7m/235.0m, Revenue 2.11b/2.22b) |
| GMI: 1.04 (GM 42.60% / 41.00%) |
| AQI: 0.94 (AQ_t 0.60 / AQ_t-1 0.64) |
| SGI: 0.95 (Revenue 2.11b / 2.22b) |
| TATA: -0.06 (NI -77.8m - CFO 117.3m) / TA 3.53b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of June 15, 2026, the stock is trading at USD 22.94 with a total of 870,330 shares traded.
Over the past week, the price has changed by +16.29%,
over one month by +38.53%,
over three months by +14.17% and
over the past year by +1.29%.
Edgewell Personal Care has received a consensus analysts rating of 3.78. Therefore, it is recommended to hold EPC.
- StrongBuy: 4
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 24.5 | 6.8% |
P/E Forward = 10.6952
P/S = 0.4732
P/B = 0.73
P/EG = 2.8727
Revenue TTM = 2.11b USD
EBIT TTM = 26.4m USD
EBITDA TTM = 112.2m USD
Long Term Debt = 1.24b USD (from longTermDebt, last quarter)
Short Term Debt = 35.1m USD (from shortTermDebt, last quarter)
Debt = 1.30b USD (from shortLongTermDebtTotal, last quarter) + Leases 16.3m
Net Debt = 996.1m USD (calculated: Debt 1.30b - CCE 299.7m)
Enterprise Value = 2.05b USD (1.06b + Debt 1.30b - CCE 299.7m)
Interest Coverage Ratio = 0.37 (Ebit TTM 26.4m / Interest Expense TTM 71.4m)
EV/FCF = 42.25x (Enterprise Value 2.05b / FCF TTM 48.6m)
FCF Yield = 2.37% (FCF TTM 48.6m / Enterprise Value 2.05b)
FCF Margin = 2.31% (FCF TTM 48.6m / Revenue TTM 2.11b)
Net Margin = -3.69% (Net Income TTM -77.8m / Revenue TTM 2.11b)
Gross Margin = 41.00% ((Revenue TTM 2.11b - Cost of Revenue TTM 1.24b) / Revenue TTM)
Gross Margin QoQ = 43.43% (prev 38.08%)
Tobins Q-Ratio = 0.58 (Enterprise Value 2.05b / Total Assets 3.53b)
Interest Expense / Debt = 5.51% (Interest Expense 71.4m / Debt 1.30b)
Taxrate = 49.37% (3.90m / 7.90m)
NOPAT = 13.4m (EBIT 26.4m * (1 - 49.37%))
Current Ratio = 1.81 (Total Current Assets 1.11b / Total Current Liabilities 613.8m)
Debt / Equity = 0.89 (Debt 1.30b / totalStockholderEquity, last quarter 1.45b)
Debt / EBITDA = 8.88 (Net Debt 996.1m / EBITDA 112.2m)
Debt / FCF = 20.50 (Net Debt 996.1m / FCF TTM 48.6m)
Total Stockholder Equity = 1.51b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.13% (Net Income -77.8m / Total Assets 3.53b)
RoE = -5.14% (Net Income TTM -77.8m / Total Stockholder Equity 1.51b)
RoCE = 0.96% (EBIT 26.4m / Capital Employed (Equity 1.51b + L.T.Debt 1.24b))
RoIC = 0.47% (NOPAT 13.4m / Invested Capital 2.85b)
WACC = 4.57% (E(1.06b)/V(2.35b) * Re(6.76%) + D(1.30b)/V(2.35b) * Rd(5.51%) * (1-Tc(0.49)))
Discount Rate = 6.76% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.21 | Cagr: -3.60%
[DCF] Terminal Value 77.97% ; FCFF base≈42.0m ; Y1≈48.1m ; Y5≈70.8m
[DCF] Fair Price = 1.50 (EV 1.07b - Net Debt 996.1m = Equity 69.2m / Shares 46.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -74.15 | EPS CAGR: -34.49% | SUE: 0.33 | # QB: 0
Revenue Correlation: -81.64 | Revenue CAGR: -2.01% | SUE: 0.05 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.63 | Chg30d=-39.73% | Revisions=-60% | Analysts=7
EPS current Year (2026-09-30): EPS=1.90 | Chg30d=-1.45% | Revisions=+11% | GrowthEPS=-24.8% | GrowthRev=-10.1%
EPS next Year (2027-09-30): EPS=2.06 | Chg30d=-7.43% | Revisions=-56% | GrowthEPS=+8.4% | GrowthRev=+1.6%
[Analyst] Revisions Ratio: -60%